Title:
PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCING SAME
Document Type and Number:
WIPO Patent Application WO/2020/122241
Kind Code:
A1
Abstract:
A pharmaceutical composition comprising an amorphous solid dispersion containing an amorphous body of lopinavir, an amorphous body of ritonavir and a cellulose-type polymeric compound and lamivudine; and a method for producing a pharmaceutical composition.
Inventors:
KANO ATSUSHI (JP)
TOYONAGA SHO (JP)
TOYONAGA SHO (JP)
Application Number:
PCT/JP2019/049013
Publication Date:
June 18, 2020
Filing Date:
December 13, 2019
Export Citation:
Assignee:
FUJIFILM CORP (JP)
International Classes:
A61K31/427; A61K9/20; A61K9/24; A61K31/513; A61K47/38
Foreign References:
| US20140234415A1 | 2014-08-21 |
Other References:
TANNO, FUMIE: "Evaluation of Characteristics of Hypromellose Acetate Succinate (HPMCAS) as a Carrier for Solid Dispersion: from Study to Improve In Vitro Dissolution of Poorly Water Soluble Drugs", JOURNAL OF PHARMACEUTICAL SCIENCE AND TECHNOLOGY, JAPAN, vol. 73, no. 4, 2013, pages 214 - 222, XP009520813, ISSN: 0372-7629, DOI: 10.14843/jpstj.73.214
Attorney, Agent or Firm:
TAIYO, NAKAJIMA & KATO (JP)
Download PDF:
Previous Patent: PNEUMATIC TIRE
Next Patent: PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCING SAME
Next Patent: PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCING SAME